On Friday, Zydus Cadila declared that the Drug Controller General of India (DCGI) had approved the emergency use of its drug ‘Virafin' for treating moderate cases of COVID-19 in adults.
A release by Cadila Health said, “The drug has also shown efficacy against other viral infections.”
Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: “The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19.”